Results 41 to 50 of about 393,592 (390)

p62 links the autophagy pathway and the ubiqutin–proteasome system upon ubiquitinated protein degradation

open access: yesCellular & Molecular Biology Letters, 2016
The ubiquitin–proteasome system (UPS) and autophagy are two distinct and interacting proteolytic systems. They play critical roles in cell survival under normal conditions and during stress.
Wei Jing Liu   +7 more
semanticscholar   +1 more source

Inhibitory Effect of b-AP15 on the 20S Proteasome

open access: yesBiomolecules, 2014
The 26S proteasome is a cellular proteolytic complex containing 19S regulatory particles and the 20S core proteasome. It was reported that the small molecule b-AP15 targets the proteasome by inhibiting deubiquitination of the 19S regulatory particles of
Li Huang, Katherine Jung, Chin Ho Chen
doaj   +1 more source

Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells. [PDF]

open access: yesPLoS ONE, 2015
Fangchinoline is a bisbenzylisoquinoline alkaloid isolated from Radix Stephaniae tetrandrae S. Moore. Fangchinoline and its structure analogue, tetrandrine, exhibited direct binding affinity with recombinant human proteasome β1 subunit and also inhibited
Dong Li   +11 more
doaj   +1 more source

Deletion of proteasomal subunit S5a/Rpn10/p54 causes lethality, multiple mitotic defects and overexpression of proteasomal genes in Drosophila melanogaster [PDF]

open access: yes, 2003
The regulatory complex of the 26S proteasome is responsible for the selective recognition and binding of multiubiquitinated proteins. It was earlier shown that the subunit S5a/Rpn10/p54 of the regulatory complex is the only cellular protein capable of ...
Andó, István   +7 more
core   +1 more source

Proteasome inhibitors

open access: yesBiochemical Pharmacology, 2015
Proteasome inhibitors have a 20 year history in cancer therapy. The first proteasome inhibitor, bortezomib (Velcade, PS-341), a break-through multiple myeloma treatment, moved rapidly through development from bench in 1994 to first approval in 2003. Bortezomib is a reversible boronic acid inhibitor of the chymotrypsin-like activity of the proteasome ...
Teicher, Beverly A.   +1 more
openaire   +2 more sources

FoxO1 Is a Novel Regulator of 20S Proteasome Subunits Expression and Activity

open access: yesFrontiers in Cell and Developmental Biology, 2021
Proteostasis collapses during aging resulting, among other things, in the accumulation of damaged and aggregated proteins. The proteasome is the main cellular proteolytic system and plays a fundamental role in the maintenance of protein homeostasis.
Marianna Kapetanou   +5 more
doaj   +1 more source

Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen species [PDF]

open access: yes, 2013
Background The radiopharmaceutical 131I-metaiodobenzylguanidine (131I-MIBG) is used for the targeted radiotherapy of noradrenaline transporter (NAT)-expressing neuroblastoma.
Babich, J.W.   +4 more
core   +3 more sources

The proteasomal system

open access: yesMolecular Aspects of Medicine, 2009
Rising interest in the mechanism and function of the proteasomes and the ubiquitin system revealed that it is hard to find any aspect of the cellular metabolic network that is not directly or indirectly affected by the degradation system. This includes the cell cycle, the "quality control" of newly synthesized proteins (ERAD), transcription factor ...
Jung, Tobias   +2 more
openaire   +4 more sources

Proteasome beta-4 subunit contributes to the development of melanoma and is regulated by miR-148b

open access: yesTumor Biology, 2017
The proteasome beta-4 subunit is required for the assembly of 20S proteasome complex, forming a pivotal component for the ubiquitin–proteasome system. Emerging evidence indicates that proteasome beta-4 subunit may be involved in underlying progression ...
Xiaodong Zhang   +7 more
doaj   +1 more source

Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides [PDF]

open access: yes, 2016
The success of inhibition of the proteasome by formation of covalent bonds is a major victory over the long held-view that this would lead to binding the wrong targets and undoubtedly lead to toxicity.
Brouwer, Arwin J.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy